Series date: 
04/01/2024 - 7:30am EDT to 12/31/2024 - 8:30am EST


In the realm of modem healthcare, diagnostic testing plays a vital role in identifying and managing various medical conditions. Clinical, diagnostic, and hospital labs utilize Quality Control Programs which serve as the backbone of accurate, reproducible, and reliable testing with minimal or no variability across the entire BHSF, enabling healthcare providers to make informed decisions about patient care.

Accurate diagnosis relies not only on the proficiency of healthcare providers but also on the quality controls implemented in diagnostic testing. High-quality QCs serve as a benchmark against which test results are compared. These controls consist of known samples with predefined values that are used to validate and monitor the accuracy and precision of test results.

By regularly running quality controls, clinical and vascular labs can detect and correct any potential errors or deviations, thereby minimizing false positives and false negatives. This ensures that healthcare providers can confidently rely on diagnostic test results for accurate diagnosis and appropriate treatment decisions throughout the patient's journey.


Physicians, Nurses, Vascular Testing Leaders and Technologists, Radiology Leaders and Technologists, and Respiratory Leaders and Technologists.


•    Self-assess facility imaging studies and reports.
•    Utilize data-driven, objective measures of quality improvement progress to comply with the IAC Standards and Guidelines for Accreditation.
•    Fulfill a variety of facility quality initiatives.
•    Visually benchmark findings and track QI progress.
•    Create a quantitative report that targets opportunities for improvements, leading to enhanced patient care.


Elliott J. Elias, M.D., MPH, FACC, FASE                                 

Medical Director of Cardiac and Structural Imaging
Miami Cardiac & Vascular Institute
Baptist Health 

Muhammad Hasan, MBBch, RPVI

Cardiovascular Clin Tech Edu 
Miami Cardiac & Vascular Institute Administration
Miami, Florida

Elliott J. Elias, M.D., conference director of this educational activity, is a consultant for Abbott Laboratories, Boston Scientific, Philips Medical and Edwards Life Sciences. All of the relevant financial relationships listed for this individual have been mitigated.

Mohammad Hasan, MBBch, RPVI, moderator of this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that his participation will not include discussion of off-label or unapproved usage.

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationship(s) with ineligible companies to disclose.*

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer


Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course # 20-1176828, by the Florida Boards of Medicine, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurse Practitioners, Nurses, Baptist Health South Florida CE Broker Provider #50-182.

Series location: 
United States